Publications

Kara Franke (13 POSTS)

2024 (4 POSTS)

Acute health-based screening level derivation for cyanotoxins (microcystin, cylindrospermopsin and anatoxins)

Reátegui-Zirena EG, Lange SS, Jenkins A, Heintz MM, Franke K, Perry CS, Thompson C, et al. Acute health-based screening level derivation for cyanotoxins (microcystin, cylindrospermopsin and anatoxins). Abstract 7.05P-Th-197, Society of Environmental Toxicology and Chemistry, 45th Annual Meeting, Fort Worth, TX, October 2024.

View Abstract

Industry-wide review of potential worker exposure to 1,3-butadiene during chemical manufacturing and processing as a reactant

Panko J, Mittal L, Franke K, Maberti S, Zollers S, Millison K, et al. 2024. Industry-wide review of potential worker exposure to 1,3-butadiene during chemical manufacturing and processing as a reactant. J Occup Environ Hyg 21(1):13-23; doi: 10.1080/15459624.2023.2264329. PMID: 37788445.

View Abstract

Assessment of non-occupational exposures to cleaning products and the incidence of asthma and respiratory disease

Franke K, Vincent M, Rogers S, Rivera B, Wikoff D. Assessment of non-occupational exposures to cleaning products and the incidence of asthma and respiratory disease. Abstract 3393, Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024.

View Abstract

Systematic update to the mammalian relative potency estimate database and development of best estimate toxic equivalency factors for dioxin-like compounds

Fitch S, Blanchette A, Haws LC, Franke K, Ring C, DeVito M, Wheeler M,… Wikoff DS. 2024. Systematic update to the mammalian relative potency estimate database and development of best estimate toxic equivalency factors for dioxin-like compounds. Regul Toxicol Pharmacol 147(Feb):105571; doi: 10.1016/j.yrtph.2024.105571. PMID: 38244664.

View Abstract

2023 (1 POST)

Cannabidiol safety data: A systematic mapping study

Henderson RG, Franke KS, Payne LE, Franzen A. 2023. Cannabidiol safety data: A systematic mapping study. Cannabis Cannabinoid Res 8(1):34–40; doi: 10.1089/can.2022.0100. PMID: 36251454.

View Abstract

2021 (2 POSTS)

Cannabidiol literature scoping review protocol

Franke K, Payne L, Franzen A, Wikoff D, Henderson R. 2021. Cannabidiol literature scoping review protocol. Center for Open Science, OSFHOME (May 20).

View Abstract

Drivers of scope of practice in family medicine: A conceptual model

Russell A, Fromewick J, Macdonald B, Kimmel S, Franke K, Leach K, Foley K. 2021. Drivers of scope of practice in family medicine: A conceptual model. Ann Fam Med 19(3):217–223; doi: 10.1370/afm.2669; PMID: 34180841.

View Abstract

2020 (2 POSTS)

Creating a literature database for cannabidiol (CBD): Systematic evidence mapping

Henderson RG, Franzen A, Franke K, Payne L, Schmitt D, Wikoff D. Creating a literature database for cannabidiol (CBD): Systematic evidence mapping. Poster for Society of Toxicology 59th Annual Meeting, Virtual, 2020.

View Abstract

Evaluation of potential human health risk associated with consumption of edible products from livestock fed ration supplemented with Red Lake Diatomaceous Earth

Wikoff DS, Bennett DC, Brorby GP, Franke KS. 2020. Evaluation of potential human health risk associated with consumption of edible products from livestock fed ration supplemented with Red Lake Diatomaceous Earth. Food Addit Contam A 37(5):804-814; doi: 10.1080/19440049.2020.1727963. PMID: 32134694.

View Abstract

2019 (1 POST)

Application of the EFSA/ECHA endocrine disruption guidance as a framework for evidence integration in a weight-of-evidence (WoE) analysis for oxybenzone (BP-3)

Borghoff S, Fitch S, Britt J, Franke K, Wikoff D. Application of the EFSA/ECHA endocrine disruption guidance as a framework for evidence integration in a weight-of-evidence (WoE) analysis for oxybenzone (BP-3). Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

2018 (1 POST)

Key findings and implications of a recent systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children

Doepker C, Franke K, Myers E, Goldberger JJ, Lieberman HR, O’Brien C, Peck J, Tenenbein M, Weaver C, Wikoff D. 2018. Key findings and implications of a recent systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Nutrients 10(10):1536; doi: 10.3390/nu10101536.

View Abstract

2011 (1 POST)

Government and Navy knowledge regarding health hazards of asbestos: A state of the science evaluation (1900 to 1970)

Franke K, Paustenbach D. 2011. Government and Navy knowledge regarding health hazards of asbestos: A state of the science evaluation (1900 to 1970). Inhal Toxicol 23(S3):1–20; doi: 10.3109/08958378.2011.643417.

View Abstract

2006 (1 POST)

Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. 2006. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition. November 4-8, 2006. Boston, MA.